Matching slides 119,566
Current window 71,311-71,340
Pages 3,986
Rows per page 30
Component: Imageclear collectionreset all

Component

71,311-71,340 of 119,566

filter-aware
14
The slide uses a visual representation of bispecific antibodies to explain their dual-target mechanism.BioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
19
The slide highlights BNT162b2 in a table and shows the SARS-COV-2 spike protein structure.BioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · Satisfaction1 hit
28
BioNTech | Results Presentation Deck | 28 slidesBioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Broadridge Financial Solutions | Results Presentation Deck | 30 slidesBroadridge Financial Solutions | Results Presentation Deck | 30 slides · Broadridge
Deck Investor relations Beat · Attention1 hit
02
Capri Holdings | Results Presentation Deck | 9 slidesCapri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Attention1 hit
06
Capri Holdings | Results Presentation Deck | 9 slidesCapri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Satisfaction1 hit
07
Capri Holdings | Results Presentation Deck | 9 slidesCapri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Satisfaction1 hit
08
Capri Holdings | Results Presentation Deck | 9 slidesCapri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Satisfaction1 hit
06
The slide uses a central logo with four surrounding callout boxes, each paired with an icon.DraftKings | Results Presentation Deck | 11 slides · DraftKings
Conference presentation Investor relations 1 hit
02
Farfetch | Results Presentation Deck | 14 slidesFarfetch | Results Presentation Deck | 14 slides · Farfetch
Conference presentation Investor relations Beat · Setup1 hit
06
The slide uses a grid layout to showcase client prestige and retention.IBEX | IPO Presentation Deck | 23 slides · ibex
Pitch deck Investment bank 1 hit
11
The slide uses a hierarchical structure to map specific product offerings under three main functional pillars.IBEX | IPO Presentation Deck | 23 slides · ibex
Pitch deck Investment bank 1 hit
09
Uses a visual metaphor of a pie chart slice expanding to show existing modalities vs the opportunity space.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
10
Kymera | IPO Presentation Deck | 49 slidesKymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
12
The chart is a dot plot showing expression abundance across various tissues for different E3 ligases and targets, categorized by expression pattern (Ubiquitous, Restrictive, Selective).Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
14
The slide uses 3D surface plots to illustrate the relationship between degrader concentration, binding affinity, and ternary complex formation, contrasting suboptimal vs. optimal outcomes.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
15
The slide uses a comparison table to show quantitative improvements in drug characteristics (potency, clearance, permeability, bioavailability).Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
18
Kymera | IPO Presentation Deck | 49 slidesKymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
27
The slide uses an abstract, fluid, blue-toned background.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
28
The slide illustrates a biological pathway and the therapeutic intervention point for a drug candidate.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
29
The slide shows a dual-axis chart comparing protein degradation percentages and cell death percentages against drug concentration.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
35
Abstract background imagery, likely representing biological or molecular structures.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
36
The slide uses a biological pathway diagram to illustrate the JAK-STAT signaling mechanism.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
37
The slide uses a hierarchical categorization (Cancer vs I/I Fibrosis) to map disease states to STAT3 mechanisms.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
40
Shows two separate line charts comparing vehicle vs STAT3 degrader at various doses.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
41
Includes a Western blot image showing protein levels under different treatment conditions.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
46
Kymera | IPO Presentation Deck | 49 slidesKymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
49
Kymera | IPO Presentation Deck | 49 slidesKymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
02
Lordstown Motors | Investor Presentation Deck | 39 slidesLordstown Motors | Investor Presentation Deck | 39 slides · Lordstown Motors
Pitch deck Investor relations 1 hit
03
Lordstown Motors | Investor Presentation Deck | 39 slidesLordstown Motors | Investor Presentation Deck | 39 slides · Lordstown Motors
Pitch deck Investor relations 1 hit